EVerZom raises €10M to advance exosome-based therapies for inflammatory diseases, led by Capital Grand Est and the EIC Fund. The funds will support clinical development and manufacturing enhancements.
Amount Raised
€10 Million
Round Type
Funding Round
ParisBiotechnologyHealth CareTherapeuticsInvestors
Description
EVerZom has raised €10 million to develop exosome-based biotherapies for inflammatory diseases. This funding will initiate clinical development of EVerGel in 2026 and enhance exosome biomanufacturing. The investors include Capital Grand Est, the EIC Fund, and others. The mission is to reach new therapeutic indications and scale production.
Quick answer
EVerZom raised €10 Million in a Funding Round round, dated October 14, 2025. Investors: Sorbonne Venture By Audacia, Aloe Private Equity, Paris Business Angels, Capital Cell Platform, European Innovation Council Fund and Capital Grand Est. EVerZom is based in Paris, Ile-de-France, France.
- How much did EVerZom raise?
- EVerZom raised €10 Million in a Funding Round round on October 14, 2025.
- Who invested in EVerZom?
- Sorbonne Venture By Audacia, Aloe Private Equity, Paris Business Angels, Capital Cell Platform, European Innovation Council Fund and Capital Grand Est are named as investors in this round.
- What does EVerZom do?
- EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver.
- Where is EVerZom based and how big is it?
- EVerZom is based in Paris, Ile-de-France, France. Fundz records about 18 employees.
- Who are the decision-makers at EVerZom?
- Fundz holds 1 contact at EVerZom. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as EVerZom that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
- Verrica raised $50M on November 25, 2025.
- FibroBiologics raised $1.5M on November 24, 2025.
- MindImmune Therapeutics raised $10M (Series A) on November 24, 2025.
- BeyondSpring raised $2M (Funding Round) on November 21, 2025.
Who to call at EVerZom, and when
A new round usually means EVerZom is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EVerZom raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EVerZom, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EVerZom. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EVerZom raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
EVerZom raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.